ZA981781B - The use of levobupivacaine in treating migraine - Google Patents

The use of levobupivacaine in treating migraine

Info

Publication number
ZA981781B
ZA981781B ZA981781A ZA981781A ZA981781B ZA 981781 B ZA981781 B ZA 981781B ZA 981781 A ZA981781 A ZA 981781A ZA 981781 A ZA981781 A ZA 981781A ZA 981781 B ZA981781 B ZA 981781B
Authority
ZA
South Africa
Prior art keywords
levobupivacaine
treating migraine
migraine
treating
Prior art date
Application number
ZA981781A
Other languages
English (en)
Inventor
Ian Ashley Evetts
Simon John Gunning
Original Assignee
Chiroscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiroscience Ltd filed Critical Chiroscience Ltd
Publication of ZA981781B publication Critical patent/ZA981781B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ZA981781A 1997-03-03 1998-03-03 The use of levobupivacaine in treating migraine ZA981781B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9704349.1A GB9704349D0 (en) 1997-03-03 1997-03-03 Levobupivacaine and its use

Publications (1)

Publication Number Publication Date
ZA981781B true ZA981781B (en) 1999-03-03

Family

ID=10808600

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA981781A ZA981781B (en) 1997-03-03 1998-03-03 The use of levobupivacaine in treating migraine

Country Status (15)

Country Link
US (1) US6019994A (xx)
EP (1) EP0967979A1 (xx)
JP (1) JP2001515479A (xx)
KR (1) KR20000075895A (xx)
CN (1) CN1128620C (xx)
AU (1) AU731127B2 (xx)
BR (1) BR9808299A (xx)
CA (1) CA2280135A1 (xx)
GB (1) GB9704349D0 (xx)
HU (1) HUP0000756A3 (xx)
IL (1) IL131085A0 (xx)
NO (1) NO994258L (xx)
PL (1) PL335562A1 (xx)
WO (1) WO1998038998A1 (xx)
ZA (1) ZA981781B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL338176A1 (en) * 1997-07-21 2000-10-09 Astra Ab Compositions and sets of means for as well as methods of inhibiting cerebral neurovascular disorders and muscular headaches
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
US6432986B2 (en) 1997-07-21 2002-08-13 Bruce H. Levin Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
AU2862200A (en) 1999-01-27 2000-08-18 Bruce H. Levin Compositions, kits, apparatus, and methods for inhibiting cerebral neurovasculardisorders and muscular headaches
WO2001043733A2 (en) * 1999-12-15 2001-06-21 Levin Bruce H Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation
US20070225781A1 (en) * 2006-03-21 2007-09-27 Nidus Medical, Llc Apparatus and methods for altering temperature in a region within the body
DE102008037682A1 (de) * 2008-08-14 2010-04-08 Strackharn, Klaus, Dr.med. Verwendung äquipotenter Dosierungen von Lokalanästetika oder Derivaten davon zur Therapie chronischer Schmerzen
EP2882745A2 (en) * 2012-05-10 2015-06-17 Cellixbio Private Limited Compositions and methods for the treatment of local pain
CN106214670B (zh) * 2016-07-25 2020-12-29 上海璃道医药科技有限公司 酰胺类药物的用途
WO2023215604A1 (en) 2022-05-05 2023-11-09 Pfof Llc Anesthetic nerve block and method
US12070454B1 (en) 2022-05-05 2024-08-27 Pfof Llc Anesthetic nerve block and method

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2135673A (en) * 1983-02-25 1984-09-05 Raychem Ltd Curable fabric
US4695576A (en) * 1984-07-09 1987-09-22 Astra Lake Medel Aktiebolag L-N-n-propylpipecolic acid-2,6-xylidide
GB9321061D0 (en) * 1993-10-13 1993-12-01 Chiroscience Ltd Analgestic agent and its use
JPH11503444A (ja) * 1995-04-13 1999-03-26 カイロサイエンス・リミテッド レボブピバカインおよびその妊婦麻酔剤としての使用
GB2315673A (en) * 1996-08-01 1998-02-11 Merck & Co Inc Treatment of migraine
PL338176A1 (en) * 1997-07-21 2000-10-09 Astra Ab Compositions and sets of means for as well as methods of inhibiting cerebral neurovascular disorders and muscular headaches

Also Published As

Publication number Publication date
NO994258L (no) 1999-11-02
WO1998038998A1 (en) 1998-09-11
HUP0000756A2 (hu) 2000-10-28
CN1249685A (zh) 2000-04-05
CN1128620C (zh) 2003-11-26
CA2280135A1 (en) 1998-09-11
EP0967979A1 (en) 2000-01-05
KR20000075895A (ko) 2000-12-26
AU731127B2 (en) 2001-03-22
GB9704349D0 (en) 1997-04-23
AU6630898A (en) 1998-09-22
US6019994A (en) 2000-02-01
BR9808299A (pt) 2002-05-21
PL335562A1 (en) 2000-05-08
NO994258D0 (no) 1999-09-02
HUP0000756A3 (en) 2000-12-28
IL131085A0 (en) 2001-01-28
JP2001515479A (ja) 2001-09-18

Similar Documents

Publication Publication Date Title
EP0964032A4 (en) NEW COMPOSITION AND TREATMENT
EP0973461A4 (en) MIGRAINE TREATMENT
HK1015272A1 (en) Hair treatment composition
GB9706486D0 (en) Hair treatment composition
ID15858A (id) Turunan triazol yang berguna dalam terapi
GB2334444B (en) Hair treatment composition and method of manufacturing the composition
PL332481A1 (en) Combination therapy useful in treating psychoses
HK1089956A1 (en) Foaming composition for hair cleaning and hair treatment
GB9418420D0 (en) Composition for the treatment of an energy imbalance in ruminents
IL136110A0 (en) Methods and compositions for the treatment of psoriasis
GB2322550B (en) Hair treatment composition
PL328463A1 (en) Disinfecting composition and surface disinfecting methods
HUP0000873A3 (en) The use of levobupivacaine in facial surgery
ZA981781B (en) The use of levobupivacaine in treating migraine
HK1018271A1 (en) Substituted benzylamines and their use for the treatment of depression
CY2482B1 (en) Paroxetine in treatment of depression.
IL111554A0 (en) Methods and compositions for hair treatment
HK1024630A1 (en) Arylsubstituted piperazines useful in the treatment of benign prostatic hyperlasia
IL143413A0 (en) Method for the activation of water and use thereof
HUP0102995A3 (en) Agents and method for the protective treatment of wood
HUP9901639A3 (en) Therapeutic anti-asthma agents
GB9704370D0 (en) Levobupivacaine and its use
PL336592A1 (en) Application of oligosaccharides in treating connective tissue
GB2331528B (en) Hair treatment composition
EP1032266A4 (en) USE OF DELTA-5-ANDROSTEN-3-BETA-OL-7,17-DION IN THE TREATMENT OF ARTHRITIS